Janus kinase (JAK) is a tyrosine kinase comprised of Janus kinase 1 (JAK1), Janus kinase 2, Janus kinase 3, and tyrosine kinase 2. JAK and signal transducer and activator of transcription signaling pathways play a pivotal role in regulating intracellular gene expression through various inflammatory cytokines. Inflammatory cytokines include interferons, interleukins, and multiple other growth factors. Dysregulation of JAK-signal transducer and activator of transcription signaling contributes to various inflammatory disorders, and JAK inhibitors (JAKi) are now considered a promising new treatment modality for multiple skin disorders, including atopic dermatitis (AD), psoriasis, psoriatic arthritis, alopecia areata, and vitiligo.